Exela Technologies, Inc.

  • Market Cap: Micro Cap
  • Industry: Computers - Software & Consulting
  • ISIN: US30162V8054
USD
0.06
0.01 (15.16%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Exela Technologies, Inc. stock-summary
stock-summary
Exela Technologies, Inc.
Computers - Software & Consulting
Exela Technologies, Inc. is a business process automation (BPA) company. The Company’s segments include Information and Transaction Processing Solutions (ITPS), Healthcare Solutions (HS), and Legal and Loss Prevention Services (LLPS). ITPS provides a range of solutions and services designed to aid businesses in information capture, processing, decisioning and distribution to customers primarily in the financial services, commercial, public sector and legal industries. HS operates and maintains a consulting and outsourcing business specializing in both the healthcare provider and payer markets. LLPS segment provides a range of support services in connection with class action, bankruptcy labor, claims adjudication and employment and other legal matters. LLPS segment serves corporate counsel, government attorneys, and law firms.
Company Coordinates stock-summary
Company Details
2701 E Grauwyler Rd , IRVING TX : 75061-3414
stock-summary
Tel: 1 314 5486200
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 4 Schemes (1.49%)

Foreign Institutions

Held by 5 Foreign Institutions (0.4%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
Mr. Par Chadha
Executive Chairman of the Board
Mr. Ronald Cogburn
Chief Executive Officer, Director
Mr. James Reynolds
Director
Mr. Martin Akins
Independent Director
Mr. Marc Beilinson
Independent Director
Mr. J. Coley Clark
Independent Director
Mr. John Rexford
Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
40 Million
(Quarterly Results - Jun 2025)
Net Profit:
-3 Million
stock-summary
Industry

Computers - Software & Consulting

stock-summary
Market cap

USD 1 Million (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-1.05

stock-summary
Return on Equity

121.44%

stock-summary
Price to Book

-0.05